Agenix Licenses Tyrian Dx Technology to Develop Microarray Device
October 25, 2012
Agenix Licenses Tyrian Dx Technology to Develop Microarray Device
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Gentel Licenses OHSU Viral Antigens for its Simian Assay
August 29, 2011 / GenomeWeb Daily News - Signature Dx to Use Affymetrix Chips for Cancer Test Development
June 28, 2010 / GenomeWeb Daily News - Skyline Licenses TrovaGene Biomarker for AML
June 21, 2010 / GenomeWeb Daily News - CGI Pledges to Launch Two More Array Tests This Year after 'Busy' Q1
May 28, 2013 / BioArray News - NanoString Takes Option to Liver Cancer Gene Signature for Possible Assay Development
April 17, 2013 / GenomeWeb Daily News